A vendor-neutral Agatston score that addresses variability in coronary artery calcium (CAC) scoring across CT scanner types improves classification of an individual’s future risk of cardiovascular ...

Coronary artery calcium (CAC) is a known risk factor for cardiovascular (CV) disease, even if clinicians maybe confused about how best to use the test. The higher a patient’s score on a CAC scan, the ...

October 16, 2009 (Baltimore, Maryland) — Patients presenting to the emergency department with chest pain should be treated aggressively regardless of any prior coronary artery calcium (CAC) score, a ...

When it comes to protecting your heart, preventative testing is key. Keeping track of important metrics like blood pressure and cholesterol can help you understand your risk of cardiovascular disease.

For select risk-enhanced individuals at intermediate risk of coronary artery disease (CAD), researchers found a way to ...

Please provide your email address to receive an email when new articles are posted on . A coronary artery calcium score of more than 300 is risk equivalent to established atherosclerotic CVD.

Last year, President Donald Trump's doctors screened him for heart disease using a test unfamiliar to many Americans. Now, research shows that that test, either alone or combined with other evaluation ...

Please provide your email address to receive an email when new articles are posted on . A deep learning algorithm quantified coronary artery calcium scores from routine chest CT scans. Patients with a ...

For both women and men with symptomatic CAD, it may be possible to determine the odds of obstructive disease using coronary artery calcium (CAC) scoring, according to a new retrospective study that ...

But that doesn’t mean people are powerless against the condition — there are some steps they can take to help reduce the risk. In addition to adopting healthier lifestyle habits, getting a specific ...

Equipped with knowledge of their coronary artery calcium (CAC) scan results and a statin prescription, patients were more likely to slow their plaque progression over 3 years. The trial studied people ...